loading

Finanzdaten der Organogenesis Holdings Inc-Aktie (ORGO)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
16.51%
101.00
86.69 115.18 130.23 109.98
Operating Expenses
26.60%
113.58
89.72 82.14 114.93 85.13
Benefits Costs and Expenses
0.32%
112.84
112.48 109.35 144.77 114.32
Costs And Expenses
0.32%
112.84
112.48 109.35 144.77 114.32
Operating Income/Loss
52.98%
-12.58
-26.75 6.242 -13.89 -3.852
Nonoperating Income/Loss
22.95%
0.742
0.963 -0.419 -0.648 -0.491
Income/Loss From Continuing Operations Before Tax
54.10%
-11.83
-25.78 5.823 -14.54 -4.343
Income Tax Expense/Benefit, Deferred
18.96%
-1.026
-1.266 -2.198 - -
Income Tax Expense/Benefit
64.81%
-2.442
-6.94 -6.508 2.503 -2.243
Income/Loss From Continuing Operations After Tax
50.16%
-9.392
-18.84 12.33 -17.04 -2.10
Net Income/Loss
50.16%
-9.392
-18.84 12.33 -17.04 -2.10
Preferred Stock Dividends And Other Adjustments
2.81
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.44%
126.85
126.30 132.58 132.57 131.86
Diluted Average Shares
0.44%
126.85
126.30 133.93 132.57 131.86
Basic Earnings Per Share
41.18%
-0.10
-0.17 0.09 -0.13 -0.02
Diluted Earnings Per Share
41.18%
-0.10
-0.17 0.09 -0.13 -0.02
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
2.81
- - - -
$29.32
price up icon 1.17%
$18.45
price up icon 3.04%
drug_manufacturers_specialty_generic RDY
$14.21
price up icon 0.04%
$10.41
price down icon 0.05%
$138.58
price up icon 1.27%
$306.14
price down icon 0.93%
Kapitalisierung:     |  Volumen (24h):